NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

MELODIOL GLOBAL HEALTH LIMITED (ME1)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of ME1: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Group
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000282840
Address: Suite 5 CPC 145 Stirling Highway Nedlands, Western Australia, 6009
Tel:  +61 (8) 9389 3180Fax: +61 8 9481 4950

Date first listed: 20/10/2016
Company Secretary: Winton Willesee
Sector: Pharmaceuticals, Biotechnology & Life Sciences 
Activities: Developing, registering and commercialising pharmaceutical-grade cannabis and hemp-based products for use across a broad spectrum of consumer, industry and research applications

News & Events

Expand this box to read and print

name changed from Creso Pharma Limited

13/06/2023

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    07/07/2021Adam Blumenthal-32,833,333$0.138$4,538,059

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    William LayManaging Director, CEO17/01/2022
    Chris GrundyFinance Director04/12/2017
    Ben QuirinNon Exec Director10/10/2022
    Boaz WachtelNon Exec Director22/11/2015
    Bruce LintonNon Exec Director17/01/2022
    Peter HatfullNon Exec Director30/11/2022
    Jodi ScottExecutive Director10/10/2022
    Micheline MacKayExecutive Director17/01/2022

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    James EllingfordExecutive Director22/11/201501/12/2022
    Adam BlumenthalNon Exec Chairman22/11/201510/10/2022
    Miri WernliExecutive Director20/10/201617/03/2021
    David RussellCOO04/04/201704/12/2017
    Simon BuckinghamNon Exec Director20/10/201601/06/2017

    Date of first appointment, title may have changed.